+3,909.1%
CMG vs GSK
+172.1%
+3,736.9%
-74.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.3% | +0.5% | -0.2% | +0.1% |
| 7D | +2.5% | +1.1% | +1.3% | +2.1% |
| 30D | +15.6% | +6.3% | +9.3% | +13.0% |
| 3M | +8.2% | +1.8% | +6.4% | +7.2% |
| 6M | +9.9% | +1.7% | +8.2% | +8.5% |
| YTD | -4.6% | +6.5% | -11.2% | -7.8% |
| 1Y | +12.4% | +9.5% | +2.9% | +7.6% |
| 3Y | -18.0% | +65.3% | -83.3% | -35.5% |
| 5Y | -5.3% | +43.7% | -49.0% | -22.8% |
| 10Y | +344.2% | +104.1% | +240.1% | +198.4% |
| All | +3,909.1% | +172.1% | +3,736.9% | +2,303.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling